deltatrials
Completed OBSERVATIONAL NCT02090803

Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells (VIRAUTO6)

Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells , Prospective, Open, Multicenter Study

Sponsor: Institut de Cancérologie de la Loire

Conditions Hematologic Diseases
Updated 7 times since 2017 Last updated: Sep 13, 2017 Started: Aug 31, 2012 Primary completion: Mar 31, 2015 Completion: Mar 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Hematologic Diseases, this trial is completed. The trial is conducted by Institut de Cancérologie de la Loire and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Oct 2017 · 9 months · monthly snapshotUnknown Status~Oct 2017 – ~Apr 2018 · 6 months · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

▶ Show 2 earlier versions

  1. Oct 2017 — Apr 2018 [monthly]

    Completed NA

    Status: Unknown Status → Completed

  2. Jan 2017 — Oct 2017 [monthly]

    Unknown Status NA

    First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institut de Cancérologie de la Loire
Data source: Institut de Cancérologie de la Loire

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations